A detailed history of Harbour Investments, Inc. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Harbour Investments, Inc. holds 3,545 shares of RCKT stock, worth $61,860. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,545
Previous 3,545 -0.0%
Holding current value
$61,860
Previous $76,000 14.47%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 15, 2023

BUY
$15.07 - $24.05 $33,606 - $53,631
2,230 Added 169.58%
3,545 $72,000
Q2 2022

Aug 15, 2022

BUY
$7.96 - $16.64 $10,467 - $21,881
1,315 New
1,315 $18,000
Q4 2021

Feb 16, 2022

SELL
$21.52 - $36.02 $47,989 - $80,324
-2,230 Closed
0 $0
Q1 2021

Aug 17, 2021

BUY
$43.34 - $65.91 $96,648 - $146,979
2,230 New
2,230 $99,000

Others Institutions Holding RCKT

About ROCKET PHARMACEUTICALS, INC.


  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $1.32B
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Harbour Investments, Inc. Portfolio

Follow Harbour Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investments, Inc. with notifications on news.